ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?

Eur J Clin Pharmacol. 2013 Mar;69(3):743-5. doi: 10.1007/s00228-012-1397-0. Epub 2012 Sep 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Antihypertensive Agents / adverse effects*
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects*
  • Cough / chemically induced*
  • Cough / genetics
  • Cough / physiopathology
  • Drug Substitution
  • Drug Therapy, Combination
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Hypertension / drug therapy*
  • Interferon-alpha / administration & dosage
  • Male
  • Middle Aged
  • Polyethylene Glycols / administration & dosage
  • Recombinant Proteins / administration & dosage
  • Ribavirin / administration & dosage
  • Ribavirin / adverse effects*
  • Risk Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a